If you are looking for a reliable supplier,we were the perfect choice !
We are a very trustworthy supplier, you can add me to learn more.
Please add me if you need
Telegram:
+852 56020328
WhatsApp:
 +852 68550672
Email:[email protected]
Threema:H4PZF6EB
CAS 14680-80-4 Metonitazene
CAS 23076-35-9 Xylazine
CAS 403860-66-2 Mtta(Mephtetramine)
CAS 71368-80-4
CAS 148553-50-8
CAS 2785346-75-8
CAS 20320-59-6
CAS 80532-66-7
CAS 102-97-6
CAS 5413-05-8
CAS 52190-28-0
CAS 28578-16-7
CAS 7361-61-7
CAS 718-08-1
CAS 40054-73-7
CAS 110-64-5

Tirzepatide CAS 2023788-19-2

2/5/10/15mg

Tirzepatide was developed to fight type 2 diabetes, but has additionally been shown to protect the cardiovascular system and act as a potent weight loss agent. Tirzepatide is a synthetic derivative of gastric inhibitory polypeptide (GIP) that has simultaneous glucagon-like peptide-1 (GLP-1) functionality as well. This combination allows Tirzepatide to lower blood glucose levels, increase insulin sensitivity, boost feelings of satiety, and accelerate weight loss.

Semaglutide CAS 910463-68-2

2/5/10/15mg

It is a derivative of the naturally occurring GLP-1, a peptide known to lower blood sugar levels and enhance insulin secretion. Research shows that Semaglutide may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Semaglutide has been shown to significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. 

Retatrutide CAS 2381089-83-2

5/10/15mg

Retatrutide (LY-3437943) is under development for the treatment of type 2 diabetes mellitus, obstructive sleep apnea, osteoarthritis, obesity and non-alcoholic fatty liver disease. The drug candidate is administered through subcutaneous and intravenous route. The drug candidate acts by targeting glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is a new molecular entity.